Immunology
-
Driving potent neutralization of a SARS-CoV-2 Variant of Concern with a heterotypic boost
This article has 13 authors:Reviewed by ScreenIT
-
Induction of SARS-CoV-2 Protein S-Specific CD8+ T Cells in the Lungs of gp96-Ig-S Vaccinated Mice
This article has 8 authors:Reviewed by ScreenIT
-
Sensitivity of infectious SARS-CoV-2 B.1.1.7 and B.1.351 variants to neutralizing antibodies
This article has 28 authors:Reviewed by ScreenIT
-
SARS-CoV-2 variants resist antibody neutralization and broaden host ACE2 usage
This article has 20 authors:Reviewed by ScreenIT
-
Twelve-month specific IgG response to SARS-CoV-2 receptor-binding domain among COVID-19 convalescent plasma donors in Wuhan
This article has 36 authors:Reviewed by ScreenIT
-
Cutting Edge: Nucleocapsid Vaccine Elicits Spike-Independent SARS-CoV-2 Protective Immunity
This article has 20 authors:Reviewed by ScreenIT
-
Immune characterization and profiles of SARS-CoV-2 infected patients reveals potential host therapeutic targets and SARS-CoV-2 oncogenesis mechanism
This article has 4 authors:Reviewed by ScreenIT
-
Differential effects of the second SARS-CoV-2 mRNA vaccine dose on T cell immunity in naive and COVID-19 recovered individuals
This article has 32 authors:Reviewed by ScreenIT
-
SARS-CoV-2 RBD-Tetanus Toxoid Conjugate Vaccine Induces a Strong Neutralizing Immunity in Preclinical Studies
This article has 44 authors:Reviewed by ScreenIT
-
Attenuation of clinical and immunological outcomes during SARS‐CoV‐2 infection by ivermectin
This article has 15 authors:Reviewed by ScreenIT